HEATHER PERKINS: Open Payments
NPI 1528567781 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 88 payments from 16 companies in 2025. Trend: 2023 $22 · 2024 $1,237 · 2025 $1,562
Food & beverage: $1,562
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $206 |
| Janssen Pharmaceuticals, Inc | 12 | $202 |
| Lundbeck LLC | 15 | $191 |
| Alkermes, Inc. | 9 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $156 |
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| Axsome Therapeutics, Inc. | 5 | $129 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
Products named: REXULTI, VRAYLAR, INVEGA SUSTENNA, ARISTADA, CAPLYTA, Auvelity, COBENFY, ABILIFY MAINTENA.
Industry payments across NE — which companies pay providers there.
